Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria

Abstract

Early diagnosis of CKD patients at risk for microalbuminuria or macroalbuminuria could facilitate clinical outcomes and long-term survival. Considering the few and limited efficacy of current biomarkers in early detection, we aim to discover plasma lipids that effectively predict the development of CKD paitents with microalbuminuria or macroalbuminuria. A total of 380 healthy controls and 1156 patients with CKD stages 3 to 5 were stratified by urine albumin-creatinine ratio as microalbuminuria (30-300 mg/g) and macroalbuminuria (> 300 mg/g). Fasting plasma samples were determined by UPLC-HDMS based on lipidomics. Quantitative realtime polymerase chain reaction, Western blot and immunohistochemical analyses were used to validate the lipid metabolism-associated pathways. Pathway analysis demonstrated that these lipids were closely associated with PPARγ, inflammatory mediator regulation of TRP channels and RAS signaling, which were intimately involved in activated NF-κB and Nrf2 pathways. We further carried out pathway validation and demonstrated that NF-κB pathway was activated in patients with macroalbuminuria compared with CKD patients with microalbuminuria, while Nrf2-associated protein expression was downregulated, which was accompanied by the up-regulation of Wnt/β-catenin signaling pathway. Four lipids including DTA, 5,8-TDA, GGD3 and DHA that showed great potential in the discrimination of CKD patients with microalbuminuria and healthy controls were selected by logistic regression analysis. Additionally, six lipid species including CDCA, glucosylceramide, GGD2, TTA, DHA and EDA that contributed to the discrimination of CKD patients with microalbuminuria and macroalbuminuria were selected by logistic LASSO regression Gangliosides were first identified and might be promising therapeutic targets for CKD patients with the different degree of albuminuria. Collectively, this study first demonstrates the

Silencing circular ANRIL protects HK-2 cells from lipopolysaccharide-induced inflammatory injury through up-regulating microRNA-9

“…NF-jB is known to be linked to many physiological behaviors such as proliferation, motility, cell death and immune responses, with increasing participation in recruiting inflammatory cytokines [35][36][37]. It has been reported that circRNA_0068087 down-regulation could suppress inflammation by restraining TLR4/NF-jB/NLRP3 complexes in human umbilical vein endothelial cells [38].…”

Redox signaling in aging kidney and opportunity for therapeutic intervention through natural products

“…Given the role of Nrf2 impairment in CKD-induced inflammation and oxidative stress [74], there are numerous studies demonstrated that pharmacological development aimed at enhancing Nrf2 expression might be exploited for preventing not only renal diseases but also myriad other pathology obstacles in which oxidative stress played a particularly paramount role in pathogenesis [4,75]. Additionally, Xiao et al highlighted that Nrf2 restoration and Keap1 inhibition dramatically ameliorated tubular injury induced by mitophagy in animal models of diabetes, underscoring Nrf2 may be a potential therapeutic target for kidney damage [76].…”

Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose‐Induced Podocyte Injury by Inhibiting the Activation of Wnt/β‐Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy

“…Wnt signaling pathway affects cell differentiation, proliferation, maturation, and viability [ 41 – 43 ]. Several studies have demonstrated the activation of Wnt/ β -catenin signaling pathway in patients with CKD [ 44 , 45 ]. In glomerular diseases such as DKD and azithromycin nephropathy, the Wnt family members of the glomerular podocytes are significantly upregulated and activate the downstream β -catenin, thereby activating the Wnt/ β -catenin signaling pathway [ 46 ].…”